These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 10470199

  • 21. Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
    Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Loening SA, Jung K.
    Cancer Lett; 2008 Sep 28; 269(1):85-92. PubMed ID: 18504068
    [Abstract] [Full Text] [Related]

  • 22. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
    Roigas J, Schulze G, Raytarowski S, Jung K, Schnorr D, Loening SA.
    Tumour Biol; 2001 Sep 28; 22(5):282-5. PubMed ID: 11553857
    [Abstract] [Full Text] [Related]

  • 23. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
    Feng G, Li G, Gentil-Perret A, Tostain J, Genin C.
    Anticancer Res; 2008 Sep 28; 28(1A):321-6. PubMed ID: 18383864
    [Abstract] [Full Text] [Related]

  • 24. Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
    Schneider J, Morr H, Velcovsky HG, Weisse G, Eigenbrodt E.
    Cancer Detect Prev; 2000 Sep 28; 24(6):531-5. PubMed ID: 11198266
    [Abstract] [Full Text] [Related]

  • 25. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
    Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED.
    Cancer; 2005 Nov 15; 104(10):2084-91. PubMed ID: 16208700
    [Abstract] [Full Text] [Related]

  • 26. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
    Kaya K, Ayan S, Gokce G, Kilicarslan H, Yildiz E, Gultekin EY.
    Scand J Urol Nephrol; 2005 Nov 15; 39(1):25-9. PubMed ID: 15764267
    [Abstract] [Full Text] [Related]

  • 27. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC, Gudas LJ, Bok D, Rando R, Nanus DM, Tickoo SK.
    Clin Cancer Res; 2003 Oct 15; 9(13):4897-905. PubMed ID: 14581364
    [Abstract] [Full Text] [Related]

  • 28. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S, Ishikawa S, Yamauchi A, Saitou S.
    Hinyokika Kiyo; 2000 Oct 15; 46(10):695-9. PubMed ID: 11215193
    [Abstract] [Full Text] [Related]

  • 29. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K, Hindermann W, von Eggeling F, Diegmann J, Haessler K, Schubert J.
    J Urol; 2005 Jun 15; 173(6):2150-3. PubMed ID: 15879877
    [Abstract] [Full Text] [Related]

  • 30. The tumor metabolome.
    Mazurek S, Eigenbrodt E.
    Anticancer Res; 2003 Jun 15; 23(2A):1149-54. PubMed ID: 12820363
    [Abstract] [Full Text] [Related]

  • 31. Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis.
    Goonetilleke KS, Mason JM, Siriwardana P, King NK, France MW, Siriwardena AK.
    Pancreas; 2007 Apr 15; 34(3):318-24. PubMed ID: 17414054
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?
    Wechsel HW, Feil G, Lahme S, Zumbragel A, Petri E, Bichler KH.
    Anticancer Res; 1999 Apr 15; 19(4A):2577-81. PubMed ID: 10470198
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
    Campbell L, Nuttall R, Griffiths D, Gumbleton M.
    Cancer; 2009 Aug 01; 115(15):3457-67. PubMed ID: 19526593
    [Abstract] [Full Text] [Related]

  • 39. Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?
    Varga Z, Hegele A, Stief T, Heidenreich A, Hofmann R.
    Urol Res; 2002 May 01; 30(2):122-5. PubMed ID: 12086017
    [Abstract] [Full Text] [Related]

  • 40. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
    Mizutani Y, Wada H, Yoshida O, Fukushima M, Kawauchi A, Nakao M, Miki T.
    Cancer; 2003 Aug 15; 98(4):730-6. PubMed ID: 12910516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.